Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity

Clinical Cancer Research

Volumn 4, Issue 2, 1998, Pages 507-515

  Coopman, Peter J ^a   Do, Michael T H ^a   Thompson, Erik W ^a   Mueller, Susette C ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CARCINOMA; CANCER INVASION; CARCINOMA CELL; CROSS LINKING; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GEL; HUMAN; HUMAN CELL; IMAGE ANALYSIS; LYSOSOME MEMBRANE; MEMBRANE VESICLE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANIMALS; BREAST NEOPLASMS; CELL SEPARATION; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; FLUORESCENT DYES; GELATIN; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MICE; NEOPLASM INVASIVENESS; PHAGOCYTOSIS; SWINE; TUMOR CELLS, CULTURED;

EID: 0031937107     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Lochter, A., and Bissell, M. J. Involvement of extracellular matrix constituents in breast cancer. Semin. Cancer Biol., 6: 165-173, 1995.
2. Stetler-Stevenson, W. G., Aznavoorian, S., and Liotta, L. A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol., 9: 541-573, 1993.
3. MacDougall, J. R., and Matrisian, L. M. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev., 14: 351-362, 1995.
4. Montcourrier, P., Mangeat, P. H., Valembois, C., Salazar, G., Sahuquet, A., Duperray, C., and Rochefort, H. Characterization of very acidic phagosomes in breast cancer cells and their association with invasion. J. Cell Sci., 107: 2381-2391, 1994.
5. Coopman, P. J., Thomas, D. M., Gehlsen, K. R., and Mueller, S. C. Integrin α3β1 participates in the phagocytosis of extracellular matrix molecules by human breast cancer cells. Mol. Biol. Cell, 7: 1789-1804, 1996.
6. Van Peteghem, M. C., Mareel, M. M., and De Bruyne, G. K. Phagocytic capacity of invasive malignant cells in three-dimensional culture. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol., 34: 193-204, 1980.
7. Bjerknes, R., Bjerkvig, R., and Laerum, O. D. Phagocytic capacity of normal and malignant rat glial cells in culture. J. Natl. Cancer Inst., 78: 279-288, 1987.
8. De Simone, P. A., East, R., and Powell, R. D., Jr. Phagocytic tumor cell activity in oat cell carcinoma of the lung. Hum. Pathol., 11: 535-539, 1980.
9. Youness, E., Barlogie, B., Ahearn, M., and Trujillo, J. M. Tumor cell phagocytosis: its occurrence in a patient with medulloblastoma. Arch. Pathol. Lab. Med., 104: 651-653, 1980.
10. Chandrasoma, P. Polymorph phagocytosis by cancer cells in an endometrial adenoacanthoma. Cancer (Phila.), 45: 2348-2351, 1980.
11. Brown, E. J. Phagocytosis. Bioessays, 17: 109-117, 1995.
12. Opdenakker, G., and Van Damme, J. Cytokines and proteases in invasive processes: molecular similarities between inflammation and cancer. Cytokine, 4: 251-258, 1992.
13. Chen, W-T. Proteolytic activity of specialized surface protrusions formed at rosette contact sites of transformed cells. J. Exp. Zool., 251: 167-185, 1989.
14. Mueller, S. C., and Chen, W-T. Cellular invasion into matrix beads: localization of beta 1 integrins and fibronectin to the invadopodia. J. Cell Sci., 99: 213-225, 1991.
15. Mueller, S. C., Yeh, Y., and Chen, W-T. Tyrosine phosphorylation of membrane proteins mediates cellular invasion by transformed cells. J. Cell Biol., 119: 1309-1325, 1992.
16. r 72,000 matrix metalloproteinase at cell surface invadopodia. Cancer Res., 53: 3159-3164, 1993.
17. Monsky, W. L., Lin, C-Y., Aoyama, A., Kelly, T., Mueller, S. C., Akiyama, S. K., and Chen, W-T. A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res., 54: 5702-5710, 1994.
18. Morphy, J. R., and Millican, T. A. Matrix metalloproteinase inhibitors: current status. Curr. Med. Chem., 2: 743-762, 1996.
19. Reich, R., Thompson, E. W., Iwamoto, Y., Martin, G. R., Deason, J. R., Fuller, G. C., and Miskin, R. Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res., 48: 3307-3312, 1988.
20. r 72,000 type IV collagenase in normal and malignant human fibroblastoid cells. Cancer Res., 52: 4540-4544, 1992.
21. Mueller, S. C., Kelly, T., Dai, M. Z., Dai, H. N., and Chen, W-T. Dynamic cytoskeleton-integrin associations induced by cell binding to immobilized fibronectin. J. Cell Biol., 109: 3455-3464, 1989.
22. Yu, M., Sato, H., Seiki, M., and Thompson, E. W. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin a in MDA-MB-231 human breast cancer cells. Cancer Res., 55: 3272-3277, 1995.
23. Thompson, E. W., Paik, S., Brunner, N., Sommers, C. L., Zugmaier, G., Clarke, R., Shima, T. B., Torri, J., Donahue, S., Lippman, M. E., Martin, G. R., and Dickson, R. B. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J. Cell Physiol., 150: 534-544, 1992.
24. Everts, V., Van der Zee, E., Creemers, L., and Beertsen, W. Phagocytosis and intracellular digestion of collagen, its role in turnover and remodelling. Histochem. J., 28: 229-245, 1996.
25. Ohta, T., Numata, M., Yagishita, H., Futagami, F., Tsukioka, Y., Kitagawa, H., Kayahara, M., Nagakawa, T., Miyazaki, I., Yamamoto, M., Iseki, S., and Onkuma, S. Expression of 16 kDa proteolipid of vacuolar-type H(+)-ATPase in human pancreatic cancer. Br. J. Cancer, 73: 1511-1517, 1996.
26. Rice, A., and Banda, M. J. Neutrophil elastase processing of gelatinase A is mediated by extracellular matrix. Biochemistry, 34: 9249-9256, 1995.
27. Baricos, W. H., Cortez, S. L., el-Dahr, S. S., and Schnaper, H. W. Extracellular matrix degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int., 47: 1039-1047, 1995.
28. Mackay, A. R., Ballin, M., Pelina, M. D., Farina, A. R., Nason, A. M., Hartzler, J. L., and Thorgeirsson, U. P. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metastasis, 12: 168-184, 1992.
29. Azzam, H. S., Arand, G., Lippman, M. E., and Thompson, E. W. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J. Natl. Cancer Inst., 85: 1758-1764, 1993.
30. Imai, K., Ohuchi, E., Aoki, T., Nomura, H., Fujii, Y., Sato, H., Seiki, M., and Okada, Y. Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res., 56: 2707-2710, 1996.
31. Montcourrier, P., Mangeat, P. H., Salazar, G., Morisset, M., Sahuquet, A., and Rochefort, H. Cathepsin D in breast cancer cells can digest extracellular matrix in large acidic vesicles. Cancer Res., 50: 6045-6054, 1990.